重新施法研究
肾脏和斑点交感神经去神经作为抗性高血压和2型糖尿病的替代疗法(重新施法研究)
To assess the safety and effectiveness of renal artery denervation with subsequent splanchnic nerves denervation via catheter-based radiofrequency ablation in improving blood pressure and glycemic control in patients with resistant hypertension and type 2 diabetes.
研究概览
详细说明
The investigators propose a multicenter, prospective, single blind, randomized controlled pilot study. Patients with treatment-resistant hypertension and diabetes mellitus type 2 will be enrolled to undergo renal artery denervation with subsequent splanchnic nerves denervation for lowering blood pressure and glycemic levels.
20 patients will be randomly selected from outpatient cardiology clinics and will be assigned (1:1) to receive an FDA approved catheter-based denervation (CDN) of the renal arteries or CDN of the renal arteries with subsequent CDN of the splanchnic nerves at the level of the celiac artery and SMA. All patients will receive non-selective renal and mesenteric artery angiography prior and post CDN. All patients will undergo office systolic and diastolic blood pressure measurements, glycemic indices (HbA1c, fasting plasma insulin, C-peptide), and other laboratory assessments (plasma norepinephrine, renin, aldosterone, angiotensin II, lipids, and liver biochemistry) at baseline and outpatient follow-up visits (months 1, 3 and 6 post procedure).
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Chris Wang, MS
- 电话号码:504-988-3065
- 邮箱:hwang37@tulane.edu
研究联系人备份
- 姓名:Suzanne Bowers, RN, BSN
- 电话号码:504-988-2030
- 邮箱:sbowers@tulane.edu
学习地点
-
-
Louisiana
-
New Orleans、Louisiana、美国、70006
- East Jefferson General Hospital
-
接触:
- Chris Wang, MS
- 电话号码:504-988-3065
- 邮箱:hwang37@tulane.edu
-
接触:
- Suzanne Bowers, RN, BSN
- 电话号码:504-988-2030
- 邮箱:sbowers@tulane.edu
-
首席研究员:
- Jose Wiley, MD, MPH, FACC, FACP, FSCAI
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients aged 18-75.
- History of Type 2 Diabetes Mellitus at least 5 years prior to enrollment.
- HbA1c level ≥6.5%
- Use of at least 1 oral antidiabetic agent and no changes in the last 30 days.
- History of essential hypertension with systolic Blood pressure of 160 mmHg or more (≥150 mmHg in patient with Type 2 Diabetes Mellitus), despite compliance with three of more antihypertensive drugs.
- Stable drug regimen of at least 3 antihypertensive medications with no changes for 2 weeks before enrollment.
Exclusion Criteria:
- Estimated glomerular filtration rate of less than 30 mL/min per 1.73m2.
- Type 1 diabetes mellitus.
- History of aortic pathologies such as aneurysm or dissection confirmed by immediate preprocedural angiography that would preclude the Endovascular Denervation (EDN) procedure.
- Orthostatic hypotension.
- Acute or severe systemic infection.
- History of myocardial infarction, unstable angina, or cerebrovascular accident in the previous 3 months.
- History of previous renal artery CDN.
- Pregnancy or planned pregnancy during the study period.
- Unable to provide informed consent.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:CDN of Renal arteries Arm
Catheter-based endovascular denervation (CDN) of renal arteries only, without splanchnic nerve denervation |
Catheter-based endovascular denervation (CDN) of renal arteries only, without splanchnic nerve denervation |
|
实验性的:CND of Renal Arteries and Splanchnic Nerves Arm
Catheter-based endovascular denervation (CDN) of renal arteries and splanchnic nerves (celiac + SMA) using radiofrequency ablation |
Catheter-based endovascular denervation (CDN) of renal arteries only, without splanchnic nerve denervation Catheter-based endovascular denervation (CDN) of renal arteries and splanchnic nerves (celiac + SMA) using radiofrequency ablation |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in office systolic and diastolic blood pressure
大体时间:Baseline, 3 months
|
To assess the change in office systolic and diastolic blood pressure measurements using blood pressure cuffs at baseline to 3 months after Catheter Based Denervation (CND) at 1 month and 3 month interval. |
Baseline, 3 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in HbA1C
大体时间:Baseline, 3 months
|
To assess the change in HbA1C from baseline to 3 months after procedure and monitor the effects of renal artery denervation with subsequent splanchnic nerves denervation. |
Baseline, 3 months
|
合作者和调查者
调查人员
- 首席研究员:Jose Wiley, MD, MPH, FACC, FACP, FSCAI、Tulane University
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.